IP Library Granted Patent US 9,242,110
Granted Patent B2
US 9,242,110 · App. 14/817,073 · Granted Jan 26, 2016

Device longevity prediction for a device having variable energy consumption

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,242,110
App. No.
14/817,073
Granted
Jan 26, 2016
Kind
B2
Abstract

A system and method for estimating the longevity of an implantable medical device (IMD). In one embodiment of a method for estimating a life of a power source of an implantable medical device, a first life estimate of the power source is determined based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed loop value corresponding to a closed-loop parameter for closed-loop therapy delivery, and prior usage data corresponding to prior therapy delivery. The first life estimate of the power source is displayed. The first life estimate displayed includes a first open-loop portion associated with open-loop therapy delivery and a first closed-loop portion associated with closed-loop therapy delivery.

Claims (67)

1. A system for estimating a life of a power source of an implantable medical device (IMD), the system comprising:

a therapy logic, wherein the therapy logic provides:

an open-loop stimulation therapy; and

a closed-loop stimulation therapy, wherein the closed-loop stimulation therapy comprises at least one of:

a patient initiated stimulation therapy; and

an event detection stimulation therapy;

a detection logic, wherein the detection logic:

detects a change in one or more body parameters;

detects a patient input; and

triggers a change from the open-loop stimulation to the closed loop stimulation therapy based upon a detection of either a change in one or more body parameter or a patient input; and

a control device, wherein the control device:

calculates an open-loop life estimate of the power source, wherein the open-loop life estimate is based upon a set of open-loop stimulation parameters;

calculates a closed-loop charge consumption, wherein the closed-loop charge consumption is based upon a set of closed loop stimulation parameters; and

provides a first operable life estimate, wherein the first operable life estimate comprises a difference resulting from subtracting the closed-loop charge consumption from the open-loop life estimate.

2. The system of claim 1 , wherein the control device is configured to update the first operable life estimate based on changing a parameter value corresponding to the open-loop therapy.

3. The system of claim 1 further comprising a communication logic, wherein the communication logic is configured to retrieve control information from the IMD and to provide the estimate of operable life to an external device.

4. The system of claim 1 , wherein at least one of the open-loop stimulation parameters comprises at least one of:

a time period;

a duty cycle, wherein the duty cycle comprises a ratio of an on-time to a combination of the on-time and an off-time;

a current magnitude;

a pulse width;

a frequency; and

burst duration.

5. The system of claim 1 , wherein at least one of the closed-loop stimulation parameters comprises at least one of:

a time period;

a duty cycle, wherein the duty cycle comprises a ratio of an on-time to a combination of the on-time and an off-time;

a current magnitude;

a pulse width;

a frequency; and

burst duration.

6. The system of claim 1 , wherein the detection logic specifies a detection level associated with each of the one or more body parameters.

7. The system of claim 1 , wherein the estimate of operable life represents the entire life of the power source.

8. The system of claim 1 , wherein the control device is further configured to store a plurality of operable life estimates.

9. The system of claim 1 , wherein the control device is configured to update the first operable life estimate based on changing a parameter value corresponding to the closed-loop therapy.

10. A method for estimating a life of a power source of an implantable medical device (IMD), the method comprising:

providing:

an open-loop stimulation therapy; and

a closed-loop stimulation therapy, wherein the closed-loop stimulation therapy comprises at least one of:

a patient initiated stimulation therapy; and

an event detection stimulation therapy;

detecting:

a change in one or more body parameters; and

a patient input;

triggering a change from the open-loop stimulation to the closed loop stimulation therapy based upon a detection of either a change in one or more body parameter or a patient input; and

calculating an open-loop life estimate of the power source, wherein the open-loop life estimate is based upon a set of open-loop stimulation parameters;

calculating a closed-loop charge consumption, wherein the closed-loop charge consumption is based upon a set of closed loop stimulation parameters; and

providing a first operable life estimate, wherein the first operable life estimate comprises a difference resulting from subtracting the closed-loop charge consumption from the open-loop life estimate.

11. The method of claim 10 further comprising updating the first operable life estimate based on changing a parameter value corresponding to the open-loop therapy.

12. The method of claim 10 further comprising updating the first operable life estimate based on changing a parameter value corresponding to the closed-loop therapy.

13. The method of claim 10 further comprising a providing the first operable life estimate to an external device.

14. The method of claim 10 , wherein at least one of the open-loop stimulation parameters comprises at least one of:

a time period;

a duty cycle, wherein the duty cycle comprises a ratio of an on-time to a combination of the on-time and an off-time;

a current magnitude;

a pulse width;

a frequency; and

burst duration.

15. The method of claim 10 , wherein at least one of the closed-loop stimulation parameters comprises at least one of:

a time period;

a duty cycle, wherein the duty cycle comprises a ratio of an on-time to a combination of the on-time and an off-time;

a current magnitude;

a pulse width;

a frequency; and

burst duration.

16. The method of claim 10 further comprises specifying a detection level associated with each of the one or more body parameters.

17. The method of claim 10 , wherein the first operable life estimate represents the entire life of the power source.

18. The method of claim 10 further comprising store a plurality of operable life estimates.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2015
From: COLBORN, JOHN C.
To: CYBERONICS, INC.
Reel/Frame 036245/0015 →